RENNES FONDATION 4
4 · XBiotech Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
XBiotech Inc.XBIT
RENNES FONDATION
10% Owner
Transactions
- Purchase
Common Stock
2019-02-28$8.19/sh+5,302$43,423→ 3,858,857 total - Purchase
Common Stock
2019-02-27$8.13/sh+5,273$42,869→ 3,853,555 total - Purchase
Common Stock
2019-03-01$8.13/sh+34,999$284,542→ 3,893,856 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.23, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.31, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $8.25, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]Number is revised to include 150,000 shares which were inadvertently omitted from prior filings.